• jump to: Main navigation
  • jump to: Main content
  • jump to: Footer

Callaghan Innovation
logo - print

Search form
  • home
    • For startups
      • Founder and Startup Support Programme
      • Gracefield Innovation Quarter
      • Learning for startups
      • Technology Incubators
      • Scaleup NZ - Innovation ecosystem platform
      • Startup case studies
      • New Zealand Product Accelerator (NZPA)

      All Startup services

      Time to get in touch?

      Contact us now

    • Funding
      • Student Grants
      • Guidelines and FAQs
      • R&D Tax Incentive
      • Grant Recipients
      • Archived Funding Products
      • New to R&D Grant
      • Ārohia Innovation Trailblazer Grant

      All funding services

      Time to get in touch?

      Contact us now

    • R&D technical
      solutions
      • Research and Development Solutions
      • New Zealand Product Accelerator
      • Trial a manufacturing robot
      • Te Whare a Māui - The Māori Innovation Hub
      • Gracefield Innovation Quarter
      • Measurement Standards Laboratory

      All R&D technical solution services

      Time to get in touch?

      Contact us now

    • Industries
      • CleanTech
      • Manufacturing & Industry 4.0
      • Primary industries
      • Food and Beverage
      • Māori Economy
      • Technology
      • Health

      All industries

      Time to get in touch?

      Contact us now

    • Networking &
      partnerships
      • Callaghan Innovation Labs
      • Gracefield Innovation Quarter
      • New Zealand Food Innovation Network (NZFIN)
      • HealthTech Activator
      • Māori economy
      • New Zealand Product Accelerator
      • Scaleup NZ - Innovation ecosystem platform
      • Te Whare a Māui - The Māori Innovation Hub

      All networking & partnerships services

      Time to get in touch?

      Contact us now

    • Learning
      • Lean programme
      • Capital Education workshop
      • Aronui: Industry 4.0 navigator experience
      • Digital Lean programme
      • Product360: product commercialisation
      • Beyond IP: Intangible asset management programme

      All learning services

      Time to get in touch?

      Contact us now

  • About
  • News and events
  • Customers
  • Careers
  • Contact
  • Subscribe

Callaghan Innovation Research Papers

Back to Research Papers

TitleAnalysis of sphingolipids, sterols, and phospholipids in human pathogenic Cryptococcus strains
Publication TypeJournal Article
Year of Publication2017
AuthorsSingh, A., MacKenzie A., Girnun G., and Poeta M.D.
JournalJournal of Lipid Research
Volume58
Issue10
Pagination2017 - 2036
Date Published2017
ISSN00222275 (ISSN)
Keywordsalpha hydroxy phytoceramide, article, controlled study, Cryptococcus gattii, Cryptococcus grubii, dihydroceramide, dihydrosphingosine 1 phosphate, enzyme metabolism, ergosterol, Filobasidiella, fungal cell, fungal strain, fungal virulence, glucosylceramide, inositolphosphorylceramide, lipid, lipid analysis, lipid metabolism, liquid chromatography-mass spectrometry, lysophosphatidylethanolamine, nonhuman, phosphatidic acid, phosphatidyl n monomethylethanolamine, phosphatidyl n,n dimethylethanolamine, Phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine, phospholipid, phytoceramide, phytosphingosine, phytosphingosine 1 phosphate, priority journal, species differentiation, Spectroscopy, sphinganine, sphingolipid, sphingosine, sphingosine 1 phosphate, sterol, unclassified drug
URLhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85030789021&doi=10.1194%2fjlr.M078600&partnerID=40&md5=b1f61228949b2b7a6c241b8c600c3a7b
DOI10.1194/jlr.M078600
  • Google Scholar
  • RTF

Back to top

  • For startups
  • Funding
  • R&D technical solutions
  • Industries
  • Networking & partnerships
  • About us
  • News and events
  • Careers
  • Customer stories
  • Contact us
  • Site map

Client login (IMS)

  • Follow on
    Facebook
  • Follow on
    Twitter
  • Connect on
    LinkedIn
  • About this site
  • Privacy policy
  • Terms and conditions